טוען...
Regulatory and policy tools to address unproven stem cell interventions in Canada: the need for action
BACKGROUND: The marketing of unproven direct-to-consumer stem cell interventions is becoming widespread in Canada. There is little evidence supporting their use and they have been associated with a range of harms. Canada has been slower to act against clinics offering these interventions than other...
שמור ב:
| הוצא לאור ב: | BMC Med Ethics |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6683337/ https://ncbi.nlm.nih.gov/pubmed/31383026 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12910-019-0388-4 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|